Marked BTZ- induced apoptosis and anti-tumor activity was noted in TNBC in vitro and in vivo, but not in HER2-overexpressing and estrogen receptor-positive breast cancer cell lines [108]. This evidence concerns the gene CASC3 and neoplasm.